Physician

David S Rho, M.D.

According to 2025 Medicare claims, David Rho, M.D. (NPI: 1932106440) practices ophthalmology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is REFOCUS EYE HEALTH OF PA, P.C. (NPI: 1962003418; TIN: 84-4619744) and primary practice location at 19114-2542.

Rho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 561 traditional Medicare patients, billed 9,315 HCPCS/CPT codes, and received $1,884,580 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,251 prescription claims across 376 beneficiaries totaling $70,597 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 43 records totaling $1,097. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $147,996 and ending at $70,597. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	492	9,113	$1,331,650
2016	521	10,298	$1,400,306
2017	535	9,271	$1,466,436
2018	538	10,859	$1,728,527
2019	524	9,220	$1,526,948
2020	468	7,883	$1,751,893
2021	613	8,775	$1,961,733
2022	636	9,970	$1,694,655
2023	634	7,461	$1,683,434
2024	561	9,315	$1,884,580

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	199	874	$147,996
2016	217	892	$92,143
2017	257	1,108	$218,079
2018	251	1,181	$326,071
2019	225	1,021	$352,376
2020	218	924	$159,507
2021	344	1,344	$74,451
2022	369	1,034	$123,910
2023	300	811	$70,873
2024	376	1,251	$70,597

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	259	556	$116
92014	Established patient complete exam of visual system	560	1,792	$85
67028	Injection of drug into eye	169	1,140	$79
92134	Imaging of retina	555	1,774	$28
92202	Extended exam of the back part of the eye with optic nerve drawing	478	740	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	43	1,568	$15,822
Ofloxacin	Ofloxacin	943	20,404	$12,064
Xiidra	Lifitegrast	14	420	$9,661
Restasis	Cyclosporine	12	345	$7,367
Cyclosporine	Cyclosporine	13	570	$6,499

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,097	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David S. Rho, M.D.?

Tedicare shows public-source Medicare data for David S. Rho, M.D. (NPI 1932106440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David S. Rho, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David S. Rho, M.D.?

David S. Rho, M.D. is linked to REFOCUS EYE HEALTH OF PA, P.C. (billing NPI 1962003418) in the available physician profile data.

Does David S. Rho, M.D. have Open Payments data?

David S. Rho, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.